Jacob Glanville on Carte Blanche South Africa

Building on the age-old understanding that blood plasma from disease survivors is rich in antibodies, scientists in laboratories around the globe – and now also in South Africa through the SA National Blood Service – are collecting blood samples from coronavirus survivors. It’s relatively cheap, needs no pharmaceutical patents and can be made by laboratories everywhere. Could convalescent plasma therapy be the game changer doctors need to help the worst COVID-19 patients in hospitals? Carte Blanche probes the science to find out.